RedHill Biopharma (RDHL) Non Operating Interest Expenses (2012 - 2023)
RedHill Biopharma (RDHL) posted Non Operating Interest Expenses of $1.46 million for the year ended Dec 31, 2025, down 3.7% from $1.51 million a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Non Operating Interest Expenses (2012 - 2023) Analysis & Trends
Since the year ended Dec 31, 2009, RedHill Biopharma has reported Non Operating Interest Expenses for 17 years.
- Annual Non Operating Interest Expenses has declined for three consecutive years, with a five-year compound annual growth rate of -35.2% (years ended Dec 2020 to Dec 2025).
- The figure for the year ended Dec 31, 2025 stands as the lowest annual Non Operating Interest Expenses since the year ended Dec 31, 2019.
- Business Quant data shows RDHL's Non Operating Interest Expenses at $1.51 million in the year ended Dec 31, 2024 (-83.7%), $9.25 million in the year ended Dec 31, 2023 (-78.2%), $42.39 million in the year ended Dec 31, 2022 (+154.4%) and $16.66 million in the year ended Dec 31, 2021 (+30.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | RedHill Biopharma | 7.09 Mn | 7.09 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 1.93 Mn |
| Mar 31, 2023 | 421,000.00 |
| Dec 31, 2022 | 2.48 Mn |
| Sep 30, 2022 | 31.78 Mn |
| Jun 30, 2022 | 4.21 Mn |
| Mar 31, 2022 | 3.91 Mn |
| Dec 31, 2021 | 3.69 Mn |
| Sep 30, 2021 | 4.01 Mn |
| Jun 30, 2021 | 4.25 Mn |
| Mar 31, 2021 | 4.75 Mn |
| Dec 31, 2020 | 4.64 Mn |
| Sep 30, 2020 | 4.22 Mn |
| Jun 30, 2020 | 3.66 Mn |
| Mar 31, 2020 | 355,000.00 |
| Dec 31, 2019 | 187,000.00 |
| Sep 30, 2019 | 161,000.00 |
| Jun 30, 2019 | 74,000.00 |
| Mar 31, 2019 | 1.03 Mn |
| Dec 31, 2018 | 44,000.00 |
| Sep 30, 2018 | 480,000.00 |
API Access
RedHill Biopharma Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();